Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07825376

Branching Scenario-Based Education in Coronary Artery Disease

Conditions: Coronary Arterial Disease (CAD)

Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 54
Sponsor: Abant Izzet Baysal University

Location: Bolu Abant İzzet Baysal University Bolu

Summary

This randomized controlled trial aims to evaluate the effects of nurse-led branching scenario-based education delivered through virtual reality and tablet on cardiovascular disease risk awareness and adherence to antiplatelet medication in patients with coronary artery disease. Participants will be randomly assigned to a virtual reality education group, a tablet-based education group, or a control group receiving routine hospital education. Cardiovascular disease risk awareness and medication adherence will be assessed before and after the educational intervention and during follow-up.

Eligibility Criteria

Inclusion Criteria: * Aged 18-65 years. * Diagnosed with coronary artery disease. * Newly initiated on antiplatelet therapy. * Conscious and able to communicate. * Physically and cognitively able to use a virtual reality headset. * Able to read, write, and understand Turkish. * Willing to provide written informed consent. * Willing to participate in the education and follow-up process. * Has not previously received education about coronary artery disease. * Able to use a smartphone. Exclusion Criteria: * Cognitive impairment or mental illness preventing communication. * Visual or hearing impairment preventing participation in the virtual reality education. * Participation in another clinical study at the same time. * Diagnosis of malignant disease. * Bleeding disorder or active bleeding risk. * Hospitalization within the previous 3 months due to acute myocardial infarction, stroke, or another serious cardiovascular event. * Unable to understand the educational materials. * Refusal to provide written informed consent.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07825376). StuddyBuddy aggregates publicly available trial information.